Gabelli Healthcare & WellnessRx Trust offers defensive healthcare exposure with attractive valuation in 2026's tech-led market rally.

The Gabelli Healthcare & WellnessRx Trust (GRX) provides investors with a defensive option amid the tech-driven market rally of 2026, trading at a 10% discount to its net asset value. The fund, with a diversified portfolio across healthcare equipment, providers, pharmaceuticals, and consumer staples, features attractive valuation metrics including a 15x price-to-earnings ratio and a 2.5x price-to-book ratio. GRX benchmarks against a blend of healthcare and consumer staples indices, reinforcing its defensive stance in a volatile market. This makes it a compelling choice for investors seeking stability during a period of high market enthusiasm for tech stocks.